Veracyte Inc
NASDAQ:VCYT
Veracyte Inc
Depreciation & Amortization
Veracyte Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Veracyte Inc
NASDAQ:VCYT
|
Depreciation & Amortization
-$25m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Veracyte Inc's Depreciation & Amortization?
Depreciation & Amortization
-25m
USD
Based on the financial report for Dec 31, 2023, Veracyte Inc's Depreciation & Amortization amounts to -25m USD.
What is Veracyte Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-52%
Over the last year, the Depreciation & Amortization growth was -4%. The average annual Depreciation & Amortization growth rates for Veracyte Inc have been -54% over the past three years , -52% over the past five years .